AG
BIIB icon

Advisor Group’s Biogen BIIB Stock Holding History

Advisor Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$4.36M Buy
14,678
+6,741
+85% +$1.87M 0.03% 457
2019
Q3 		$1.85M Sell
7,937
-686
-8% -$160K 0.01% 795
2019
Q2 		$2.02M Sell
8,623
-2,879
-25% -$665K 0.02% 754
2019
Q1 		$2.72M Sell
11,502
-1,423
-11% -$448K 0.02% 602
2018
Q4 		$3.89M Buy
12,925
+1,432
+12% +$457K 0.04% 380
2018
Q3 		$4.06M Buy
11,493
+3,163
+38% +$1.09M 0.04% 384
2018
Q2 		$2.42M Sell
8,330
-558
-6% -$157K 0.03% 483
2018
Q1 		$2.43M Sell
8,888
-2,307
-21% -$716K 0.03% 484
2017
Q4 		$3.56M Sell
11,195
-408
-4% -$131K 0.05% 350
2017
Q3 		$3.63M Buy
11,603
+1,116
+11% +$330K 0.06% 308
2017
Q2 		$2.85M Sell
10,487
-170
-2% -$45K 0.05% 362
2017
Q1 		$2.91M Sell
10,657
-1,486
-12% -$420K 0.06% 333
2016
Q4 		$3.44M Buy
12,143
+3,517
+41% +$1.04M 0.08% 271
2016
Q3 		$2.7M Sell
8,626
-1,210
-12% -$358K 0.06% 321
2016
Q2 		$2.38M Buy
+9,836
New +$2.59M 0.06% 330

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advisor Group's BIIB Position: Q4 2019 in Review

Advisor Group increased its Biogen (BIIB) stake by 85% in Q4 2019, buying an estimated $1.87M and bringing the position to 14,678 shares worth $4.36M. The position accounts for 0.03% of the portfolio, ranked #457.

Advisor Group first reported a position in BIIB in Q2 2016 and has held it in 15 quarters since. 1,102 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Advisor Group held 14,678 shares of Biogen worth $4.36M as of Q4 2019.
  • Advisor Group bought 6,741 Biogen shares in Q4 2019, an estimated $1.87M.
  • Biogen made up 0.03% of Advisor Group's portfolio in Q4 2019, its #457 holding.
  • Advisor Group first reported a position in Biogen in Q2 2016 and has held it in 15 quarters since.
  • 1,102 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.